Literature DB >> 11910190

Snake venom prothrombin activators homologous to blood coagulation factor Xa.

J S Joseph1, R M Kini.   

Abstract

We have recently determined the complete amino acid sequence of trocarin, a group D prothrombin activator from the venom of Tropidechis carinatus (Australian rough-scaled snake). This proteinase is both functionally and structurally similar to mammalian blood coagulation factor Xa. It shows approximately 70% homology and possesses the characteristic Gla domain, two EGF domains and serine proteinase domain. To examine structure-function relationships, we generated a molecular model of trocarin based on a human factor Xa des-Gla crystal structure (1xka) as template. Based on known sites of interaction between mammalian factor Xa, factor Va and prothrombin, structure-function relationships of trocarin were explored. Unlike factor Xa, trocarin is glycosylated and has a large carbohydrate moiety at the entrance to its active site pocket. This might contribute to differences observed in the kinetics of hydrolysis of synthetic substrates by trocarin as compared to human factor Xa. A Ca(2+)-binding loop present in the heavy chain of factor Xa also seems to be lost in trocarin. In addition to its role in hemostasis, factor Xa shows other biological effects, including inflammation via its interaction with effector protease receptor-1 (EPR-1). Interestingly, the EPR-1 recognition site is distinctly different in trocarin, the functional consequences of which are being investigated. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11910190     DOI: 10.1159/000048068

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  7 in total

1.  Dual function of a bee venom serine protease: prophenoloxidase-activating factor in arthropods and fibrin(ogen)olytic enzyme in mammals.

Authors:  Young Moo Choo; Kwang Sik Lee; Hyung Joo Yoon; Bo Yeon Kim; Mi Ri Sohn; Jong Yul Roh; Yeon Ho Je; Nam Jung Kim; Iksoo Kim; Soo Dong Woo; Hung Dae Sohn; Byung Rae Jin
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

2.  Coagulating Colubrids: Evolutionary, Pathophysiological and Biodiscovery Implications of Venom Variations between Boomslang (Dispholidus typus) and Twig Snake (Thelotornis mossambicanus).

Authors:  Jordan Debono; James Dobson; Nicholas R Casewell; Anthony Romilio; Bin Li; Nyoman Kurniawan; Karine Mardon; Vera Weisbecker; Amanda Nouwens; Hang Fai Kwok; Bryan G Fry
Journal:  Toxins (Basel)       Date:  2017-05-19       Impact factor: 4.546

Review 3.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

4.  Pathology-specific experimental antivenoms for haemotoxic snakebite: The impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms.

Authors:  Nessrin Alomran; Jaffer Alsolaiss; Laura-Oana Albulescu; Edouard Crittenden; Robert A Harrison; Stuart Ainsworth; Nicholas R Casewell
Journal:  PLoS Negl Trop Dis       Date:  2021-08-18

5.  A comparative cross-reactivity and paraspecific neutralization study on Hypnale hypnale, Echis carinatus, and Daboia russelii monovalent and therapeutic polyvalent anti-venoms.

Authors:  Vaddaragudisalu D Sandesha; Bhaskar Darshan; Chandrashekar Tejas; Kesturu S Girish; Kemparaju Kempaiah
Journal:  PLoS Negl Trop Dis       Date:  2022-03-28

6.  Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming.

Authors:  Nessrin Alomran; Raja Chinnappan; Jaffer Alsolaiss; Nicholas R Casewell; Mohammed Zourob
Journal:  Toxins (Basel)       Date:  2022-07-08       Impact factor: 5.075

7.  Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.

Authors:  Nessrin Alomran; Patricia Blundell; Jaffer Alsolaiss; Edouard Crittenden; Stuart Ainsworth; Charlotte A Dawson; Rebecca J Edge; Steven R Hall; Robert A Harrison; Mark C Wilkinson; Stefanie K Menzies; Nicholas R Casewell
Journal:  Toxins (Basel)       Date:  2022-06-29       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.